Blood Transfusion Devices Market Report Provides Insights Into Market Evolution And Growth Prospects

The blood transfusion devices sector is set for significant expansion as advancements in technology and healthcare infrastructure continue to evolve. With growing needs in medical procedures and rising regulatory frameworks, this market is poised for steady growth and innovation in the coming years. Let's explore the market's projected valuation, key players, driving trends, and detailed segment analysis to get a clearer picture of its future trajectory.

Forecasted Market Size and Growth Rate of the Blood Transfusion Devices Market
The blood transfusion devices market is anticipated to grow substantially, reaching a valuation of $7.55 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 6.7% over the forecast period. Several factors contribute to this surge, including advancements in automated apheresis and component separation technologies, a rising preference for minimally invasive surgeries, the broadening of blood bank infrastructure, stricter regulatory requirements for transfusion devices, and the increasing incorporation of smart monitoring and digital tracking systems within transfusion processes. Additionally, key trends shaping the market include the rising adoption of automated blood component separators, greater implementation of pathogen reduction technologies, innovations in blood bags and related accessories, growth in specialized venous access devices, and increased demand for blood storage and transfusion equipment.

Download a free sample of the blood transfusion devices market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19341&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Prominent Companies Leading the Blood Transfusion Devices Market
The competitive landscape in the blood transfusion devices market features several influential companies. These include BAG Health Care GmbH, Grifols S.A., Bio-Rad Laboratories Inc., Abbott Laboratories, Immucor Inc., Ortho Clinical Diagnostics, Siemens Healthineers, Beckman Coulter Inc., Diagast SAS, QuidelOrtho Corporation, Danaher Corporation, Becton dic*kinson and Company, Quotient Biodiagnostics, Sysmex Corporation, HemoCue AB, Agena Bioscience Inc., Tulip Diagnostics P Ltd, Merck KGaA, Trinity Biotech, MTC Med Testconsult GmbH, BioMedomics Inc, Agappe Diagnostics Ltd, and Day Medical SA.

Strategic Acquisition Strengthening Market Presence
In March 2023, Spain-based biomaterials manufacturer Werfen S.A. acquired Immucor Inc., a US-based blood transfusion device provider, for $2 billion. This move significantly enhances Werfen's foothold in the transfusion and transplant sectors, complementing their existing expertise in hemostasis, acute care, and autoimmunity product lines. The acquisition reflects a strategic effort to consolidate market presence and broaden product offerings in related medical fields.

View the full blood transfusion devices market report:
https://www.thebusinessresearchcompany.com/report/blood-transfusion-devices-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Emerging Trends Driving Innovation in Blood Transfusion Devices
Key players in the blood transfusion devices market are placing strong emphasis on the development of cutting-edge blood grouping and testing technologies to differentiate themselves. Blood grouping and testing solutions are critical in determining blood type compatibility and ensuring safe transfusions. For example, in June 2024, French biopharmaceutical company Innobiochips launched Omnys, a novel transfusion device designed to enhance laboratory efficiency and accuracy. Omnys employs multiplex analysis to deliver high-resolution testing of blood components, covering standard ABO/D typing and extended phenotyping. It integrates multiple technologies to streamline workflows, reducing the required number of testing wells and minimizing laboratory waste.

Detailed Segment Breakdown of the Blood Transfusion Devices Market
This report categorizes the blood transfusion devices market based on product type, application, and end user.

By Product Type, the segments include Pathogen Reduction Systems, Apheresis Devices, Blood Component Separators, Blood Bags and Accessories, Venous Access Devices, and Other Product Types. Subcategories under these include Plasma and Platelet pathogen reduction devices; Plasma, Platelet, and Red Blood Cell apheresis devices; automated and manual blood component separators; single to quadruple blood bags along with tubing and clamps; peripheral, central, peripherally inserted central catheters (PICCs), and implantable ports; as well as blood warmers, mixers, transfusion sets and filters, and storage and refrigeration systems.

By Application, the market is split among cardiovascular surgeries, orthopedic surgeries, neurological surgeries, obstetrics and gynecological surgeries, and other medical uses.

By End User, the principal segments cover hospitals, ambulatory surgical centers, blood banks, and other users.

Regional and market dynamics insights are also included in the broader analysis, providing a comprehensive view of global trends affecting the blood transfusion devices industry.

New strategic additions in our 2026 market reports include market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, along with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.